Gln277 and Phe554 residues are involved in thermal inactivation of protective antigen of Bacillus anthracis

被引:16
作者
Singh, S [1 ]
Ahuja, N [1 ]
Chauhan, V [1 ]
Rajasekaran, E [1 ]
Waheed, SM [1 ]
Bhat, R [1 ]
Bhatnagar, R [1 ]
机构
[1] Jawaharlal Nehru Univ, Ctr Biotechnol, New Delhi 110067, India
关键词
thermostabilization; protective antigen (PA); Bacillus anthracis;
D O I
10.1016/S0006-291X(02)02049-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protective antigen (PA) is the main component of all the vaccines against anthrax. The currently available vaccines have traces of other proteins that contribute to its reactogervicity. Thus, purified PA is recommended for human vaccination. PA loses its biological activity within 48 h at 37degreesC and its thermolability has been a cause of concern as accidental exposure to higher temperatures during transportation or storage could decrease its efficacy. In the present study, we have used protein engineering approach to increase the thermostability of PA by mutating amino acid residues on the surface as well as the interior of the protein. After screening several mutants, the mutants Gln277Ala and Phe554Ala have been found to be more thermostable than the wild-type PA. Gln277Ala retains similar to45% and Phe554Ala retains similar to90% activity, even after incubation at 37degreesC for 48 h while in the same period wild-type PA loses its biological activity completely. It is the first report of increasing thermostability of PA using site-directed mutagenesis. Generation of such mutants could pave the way for better anthrax vaccines with longer shelf life. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:1058 / 1062
页数:5
相关论文
共 34 条
[1]   Hydrophobic residues Phe552, Phe554, Ile562, Leu566, and Ile574 are required for oligomerization of anthrax protective antigen [J].
Ahuja, N ;
Kumar, P ;
Bhatnagar, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (02) :542-549
[2]  
ARNOLD FH, 1999, ANN NY ACAD SCI, V18, P400
[3]   RAPID LETHAL EFFECT IN RATS OF A THIRD COMPONENT FOUND UPON FRACTIONATING TOXIN OF BACILLUS ANTHRACIS [J].
BEALL, FA ;
TAYLOR, MJ ;
THORNE, CB .
JOURNAL OF BACTERIOLOGY, 1962, 83 (06) :1274-&
[4]   FIELD-EVALUATION OF A HUMAN ANTHRAX VACCINE [J].
BRACHMAN, PS ;
FEKETY, FR ;
GOLD, H ;
WERRIN, M ;
INGRAHAM, NR ;
PLOTKIN, SA .
AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1962, 52 (04) :632-+
[5]   Constitutive expression of protective antigen gene of Bacillus anthracis in Escherichia coli [J].
Chauhan, V ;
Singh, A ;
Waheed, SM ;
Singh, S ;
Bhatnagar, R .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (02) :308-315
[6]   Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor [J].
Duesbery, NS ;
Webb, CP ;
Leppla, SH ;
Gordon, VM ;
Klimpel, KR ;
Copeland, TD ;
Ahn, NG ;
Oskarsson, MK ;
Fukasawa, K ;
Paull, KD ;
Vande Woude, GF .
SCIENCE, 1998, 280 (5364) :734-737
[7]  
FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123
[8]   THERMAL STABILIZATION OF THYMIDYLATE SYNTHASE BY ENGINEERING 2 DISULFIDE BRIDGES ACROSS THE DIMER INTERFACE [J].
GOKHALE, RS ;
AGARWALLA, S ;
FRANCIS, VS ;
SANTI, DV ;
BALARAM, P .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 235 (01) :89-94
[9]   Expression and purification of the recombinant protective antigen of Bacillus anthracis [J].
Gupta, P ;
Waheed, SM ;
Bhatnagar, R .
PROTEIN EXPRESSION AND PURIFICATION, 1999, 16 (03) :369-376
[10]  
Hanna P, 1998, CURR TOP MICROBIOL, V225, P13